Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001104659-25-102646
Filing Date
2025-10-27
Accepted
2025-10-27 17:14:28
Documents
5

Document Format Files

Seq Description Document Type Size
1 DFAN14A tm2529507d3_dfan14a.htm DFAN14A 37295
2 GRAPHIC tm2529507d3_dfan14aimg01.jpg GRAPHIC 64285
3 GRAPHIC tm2529507d3_dfan14aimg02.jpg GRAPHIC 12642
4 GRAPHIC tm2529507d3_dfan14aimg03.jpg GRAPHIC 27386
5 GRAPHIC tm2529507d3_dfan14aimg04.jpg GRAPHIC 32342
  Complete submission text file 0001104659-25-102646.txt   227952
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filed by) CIK: 0001114448 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: DFAN14A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3020 CALLAN ROAD SAN DIEGO CA 92121
Business Address 3020 CALLAN ROAD SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Subject) CIK: 0001599901 (see all company filings)

EIN.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-39321 | Film No.: 251420629
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)